EKF Diagnostics (LON:EKF – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%.
EKF Diagnostics Stock Performance
Shares of EKF Diagnostics stock traded down GBX 0.30 during trading on Tuesday, hitting GBX 25.70. 84,764 shares of the company’s stock traded hands, compared to its average volume of 312,794. EKF Diagnostics has a 1 year low of GBX 22 and a 1 year high of GBX 31.70. The business has a 50-day simple moving average of GBX 25.44 and a 200-day simple moving average of GBX 25.51. The stock has a market capitalization of £110.04 million, a P/E ratio of 54.68 and a beta of 0.50. The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- SpaceX Defies Gravity With a Nasdaq-100 Double-Weighting Boost
- Navan’s Strong Quarter Meets an AI Spending Reality Check
- LightPath’s Defense Pivot Could Send Shares Higher
- Clearance to Climb: Why Allegiant Has Room to Fly
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
